Publication | Open Access

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study

VaccinationVaccine SafetyVaccine DevelopmentGlobal HealthVirologyFlavivirus-naive Healthy AdultsMedicineRecombinant LiveArbovirusFlavivirusVector Borne DiseaseTetravalent Dengue Vaccine